down arrow

Immuno-Biological Laboratories Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3921300004
JPY
1,528.00
-257 (-14.4%)

Dec 11

TKS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
969.53
816.70
794.62
647.58
602.75
576.69
781.22
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
969.53
816.70
794.62
647.58
602.75
576.69
781.22
Raw Material Cost
341.19
301.38
267.91
270.88
255.89
359.36
320.93
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.26
1.13
1.07
0.64
0.75
0.93
1.35
Selling and Distribution Expenses
299.97
274.34
295.38
310.33
320.73
494.34
397.30
Other Expenses
11.78
12.89
17.86
18.79
26.64
31.74
23.53
Total Expenditure (Excl Depreciation)
760.19
705.70
742.94
769.79
843.73
1,172.05
954.90
Operating Profit (PBDIT) excl Other Income
209.3
111
51.7
-122.2
-241
-595.4
-173.70000000000002
Other Income
1.38
15.30
-144.24
-143.33
-69.93
-69.28
19.28
Operating Profit (PBDIT)
226.16
128.63
-107.45
-265.54
-310.91
-664.64
-154.40
Interest
1.26
1.13
1.07
0.64
0.75
0.93
1.35
Exceptional Items
0.39
-0.52
-172.09
16.04
1.03
6.88
-8.26
Gross Profit (PBDT)
628.34
515.32
526.71
376.70
346.86
217.34
460.29
Depreciation
15.43
2.33
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
209.86
124.64
-280.61
-250.14
-310.63
-658.69
-164.00
Tax
-39.19
-62.05
9.12
8.62
8.20
9.43
3.32
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
249.05
186.69
-289.73
-258.77
-318.83
-668.12
-167.32
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
249.05
186.69
-289.73
-258.77
-318.83
-668.12
-167.32
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
249.05
186.69
-289.73
-258.77
-318.83
-668.12
-167.32
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,514.36
1,265.31
1,078.62
1,368.35
1,629.28
1,948.46
2,145.76
Earnings per share (EPS)
26.74
20.05
-31.11
-27.78
-34.23
-76.01
-19.83
Diluted Earnings per share
26.74
20.05
-31.11
-27.78
-34.23
-76.01
-19.83
Operating Profit Margin (Excl OI)
21.59%
13.59%
4.63%
-18.87%
-39.98%
-103.24%
-22.23%
Gross Profit Margin
23.24%
15.55%
-35.31%
-38.63%
-51.54%
-114.22%
-20.99%
PAT Margin
25.69%
22.86%
-36.46%
-39.96%
-52.9%
-115.85%
-21.42%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 18.71% vs 2.78% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 33.37% vs 164.45% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 98.41% vs 207.88% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Immuno-Biological Laboratories Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
969.53
32,908.42
-31,938.89
-97.05%
Other Operating Income
0.00
0.00
0.00
Total Operating income
969.53
32,908.42
-31,938.89
-97.05%
Raw Material Cost
341.19
27,175.26
-26,834.07
-98.74%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.26
37.63
-36.37
-96.65%
Selling and Distribution Expenses
299.97
4,969.17
-4,669.20
-93.96%
Other Expenses
11.78
-3.76
15.54
413.30%
Total Expenditure (Excl Depreciation)
760.19
32,144.44
-31,384.25
-97.64%
Operating Profit (PBDIT) excl Other Income
209.35
763.99
-554.64
-72.60%
Other Income
1.38
156.79
-155.41
-99.12%
Operating Profit (PBDIT)
226.16
1,220.67
-994.51
-81.47%
Interest
1.26
37.63
-36.37
-96.65%
Exceptional Items
0.39
-57.68
58.07
100.68%
Gross Profit (PBDT)
628.34
5,733.16
-5,104.82
-89.04%
Depreciation
15.43
299.89
-284.46
-94.85%
Profit Before Tax
209.86
825.46
-615.60
-74.58%
Tax
-39.19
251.16
-290.35
-115.60%
Provisions and contingencies
0
0
0.00
Profit After Tax
249.05
586.63
-337.58
-57.55%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
249.05
586.63
-337.58
-57.55%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
-12.33
12.33
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
249.05
574.30
-325.25
-56.63%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,514.36
7,654.07
-6,139.71
-80.21%
Earnings per share (EPS)
26.74
101.22
-74.48
-73.58%
Diluted Earnings per share
26.74
101.22
-74.48
-73.58%
Operating Profit Margin (Excl OI)
21.59%
2.32%
0.00
19.27%
Gross Profit Margin
23.24%
3.42%
0.00
19.82%
PAT Margin
25.69%
1.78%
0.00
23.91%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 96.95 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 18.71% vs 2.78% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 24.90 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 33.37% vs 164.45% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.48 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 98.41% vs 207.88% in Mar 2024

Annual - Interest
Interest 0.13 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.59%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."